DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Takeover 
Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America 
2021-08-02 / 19:10 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Berlin, 2 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) acquired Ambientis Radioproteção, based in Sao 
Paulo, Brazil, effective July 31^st, 2021 via its subsidiary Eckert & Ziegler Brasil Isotope Solutions Ltda (EZBIS). 
The business with annual sales in the low single-digit million range and 24 employees and specialists have been 
integrated into EZBIS's Special Transportation Business Unit. 
Ambientis has 25 years of experience in radiation protection services and holds Brazil's and LATAM's only ISO-17025 
certified counting laboratory. The company will allow EZBIS to expand its products and services offerings to the Latin 
American market and to expand the laboratory testing provided to this market. Ambientis' Laboratory will be integrated 
into the Eckert & Ziegler's counting laboratory global network as it has its own regional radiological protection 
structure and all the required authorizations to handle substances based on isotope technology. 
"Eckert & Ziegler is focusing on organic growth as well as strategic acquisitions in the expansion of its business. 
This acquisition is a further step in our growth strategy in South America, one of the world's most dynamic healthcare 
markets. EZBIS and Ambientis have multiple business synergies and their combined capabilities will help to expand our 
market opportunities not only for the Industrial segment but also for the Radiopharma and Nuclear Medicine segments in 
the region," said Claudia Goulart, President of Brasil Isotope Solutions of Eckert & Ziegler AG. 
About Eckert & Ziegler. 
Eckert & Ziegler Strahlen- und Medizintechnik AG with her 800 employees is a leading specialist for isotope-related 
components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the 
radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler 
shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse. 
Contributing to saving lives. 
Your contact: 
Eckert & Ziegler AG, Karolin Riehle, Investor Relations 
Robert-Rössle-Str. 10, 13125 Berlin, Germany 
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 
=---------------------------------------------------------------------------------------------------------------------- 
2021-08-02 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG 
              Robert-Rössle-Str.10 
              13125 Berlin 
              Germany 
Phone:        +49 30 941084-138 
Fax:          +49 30 941084-112 
E-mail:       karolin.riehle@ezag.de 
Internet:     www.ezag.de 
ISIN:         DE0005659700 
WKN:          565970 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1223429 
 
End of News   DGAP News Service 
=------------

1223429 2021-08-02


 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1223429&application_name=news

(END) Dow Jones Newswires

August 02, 2021 13:10 ET (17:10 GMT)